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To attempt to explain the non-reversal, contrary to the widely held view, of the neurological
deficits complicating chronic myeloid leukaemia.
Using patients' case folders and haematological malignancy register all cases of chronic myeloid
leukaemia seen in Jos University Teaching Hospital between July 1995 and June 2005 were retrospectively
studied. All the available literature on the subject was also reviewed.
Thirty-three cases of chronic myeloid leukaemia were seen within the study period. Five (15.15%)
of them had one or more sensori-neural defects. Of the five, two (40%) patients presented with bilateral
hearing impairment, each beginning with the left ear; one (20%) presented with left ear hearing loss; one
(20%) came with severe left ear tinnitus; one (20%) presented with complete bilateral hearing and bilateral
visual losses. Fundoscopy showed leukaemic deposits on the retina. Other causes of blindness and
deafness, e.g. trauma and foreign body in the ear respectively, were excluded.
While the complications due to hyperleucocytosis-induced stasis recover following the
conventional treatment, those due to other pathogenetic mechanisms such as leukaemic deposits do not
return to their pre-morbid states following disease control despite the use of the currently available
treatment protocols.
For future research, more still needs to be done to elicit other uncommon pathogenetic mechanisms
underlying these complications with a view to finding specific treatment measures for worrisome chronic
myeloid leukaemia-related sensori-neural deficits.
Neurological complications, chronic myeloid leukaemia, cure.
INTRODUCTION
Neurological complications of chronic myeloid
leukaemia (CML) are rare but when they occur, their
presence is a serious concern for patient and
physician. About 15% to 25% of patients present
with these complications which include :
CNS- Dizziness, slurred speech, delirium, stupor,
intracranial (cerebral) haemorrhage.
SPECIALSENSORYORGANS:
Eye- Visual blurring, diplopia,papilloedema,
retinal vein distension, retinal haemorrhages,
blindness.
Ear- Tinnitus, partial hearing, deafness.
PENIS Priapism
Usually, these neurological deficits are said to
respond to rapid cytoreductive measures like
leukapheresis and hydroxyurea therapy . In our
centre, we use hydroxyurea or busulphan but not
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experience, neurological complications do not
regress with these drugs and we do not think that this
is merely due to the absence of leukapheresis alone.
This observation prompted a review of the
neurological complications seen in CML in our
centre in an attempt to explain this unusual finding.
In a retrospective study, using patients' case folders
and haematological malignancy register all cases of
CML seen in Jos University Teaching Hospital
(JUTH) between July 1995 and June 2005 were
examined. They all had full blood count and bone
marrow aspiration done to establish diagnosis.
Cytogenetics was not done for lack of facilities.
Those who had hearing difficulty had limited ear,
nose and throat examination done. The blind patient
had fundoscopy done. Detailed hearing tests were not
done for lack of personnel and facilities at the time of
presentation.
They were all initially admitted for investigations,
rehydration and commencement of drug therapy
namely hydroxyurea 1 2g daily in divided doses or
busulphan 4 10mg daily and allopurinol 300mg
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Table 1:
Table 2:
Case serial number (year of presentation):




In CMLSeen In JUTH, July 1995 June 2005
Clinical Features of CML, Chronic Phase
at Diagnosis
KEY:
Laboratory Features At Presentation
And Outcome Following Commencement Of
Treatment
daily. They were all later followed up in
haematology out patient clinic.
Available literature on the subject was also
reviewed.
Thirty- three cases of CML were seen within the
study period. They were made up of 19 males and 14
females giving a ratio of 1.4 to 1 . Five
(15.15%) of them had one or more sensori neural
defects. Of the five two (40%) patients presented
with bilateral hearing impairment, each beginning
with the left ear; one (20%) presented with left ear
hearing loss; one (20%) came with severe left ear
tinnitus; one (20%) presented with complete
bilateral hearing and bilateral visual losses .
Fundoscopy showed leukaemic deposits on the
retina. Other causes of blindness and deafness, e.g.
trauma and foreign body in the ear respectively, were
excluded. Aural and ocular affectations accounted
for 80% and 20% of all the impairments respectively,
making the former the commoner affectation
. shows the laboratory features at
presentation and outcome following commencement
of treatment. Clinical and haematological disease
controls were achieved within 8 weeks of
presentation except in case 4 who was never
controlled before his death at 4 months after
presentation.
Over the various periods of follow up no clinically
significant improvement was noticed in any of them
(except mild reduction in the tinnitus), not even in







Year & Sex Distribution of CMLin JUTH
July 1995 June 2005.
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This might be the cause of his blindness and it did not
respond to cytoreduction.
All our patients had confirmed CML. However,
contrary to previous reports, our patients, except case
4, (Table 3), had relatively lower total white cell
count (105 150 X 10 /L) than what the previous
reports suggested (430 620) was associated with
neurological deficits. So, lack of improvement in our
patients suggests that they might have presented with
pathogenetic mechanisms other than the popular
hyperviscosity syndrome noted previously. This
might as well explain the reason for the post disease
control non-reversal of the defects we saw. This is
supported by the report of Schocket et al . We believe
that case 4 patient had other pathogenetic
mechanisms other than hyperviscosity and
leukaemic infiltration. Unfortunately, post mortem in
him because he died at home within 4 months of
presentation and was buried before we were told.
It was also observed that occurrence of more than one
neurological complication is a sign of poor prognosis
as seen in case 4 who had total bilateral blindness and
bilateral deafness and died within 4 months of
presentation.
Established neurological complications of CML due
to pathogenet ic mechanisms other than
hyperleucocytosis-induced stasis do not return to
their pre-morbid states despite adequate treatment.
As at now, there does not appear to be any cure for
neurological complications resulting from such
mechanisms. More still needs to be done to unveil
other uncommon pathogenetic mechanisms
responsible for the non-reversal of these
complications with a view to finding specific
curative measures for them.
Professor BN Okeahialam for proof reading this
article.
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Case 1(2000); Case 2(2003); Case 3(2004); Case
4(2005); Case 5(2005)
= Packed Cell volume
= Total white blood cell count
: means no change; ± means little
or no change.
Neurological complications of CML are rare but
their occurrence places a serious concern on the
patient and physician. Cure, where possible, will
therefore bring a great relief to both patient and
physician.
More males were affected in our study as opposed to
previous study . This suggests that there is no fixed
sex pattern of affectation. Aural defects
complicating CMLare commoner (80%) than ocular
defects (20%) as seen in our study (Table 2). This
agrees with previous reports . A new finding in our
study is the vulnerability of the left ear to
neurological complications seen in CML. When the
ear was involved, it was either the left ear alone or
where the two ears were involved it either started
from the left side or worse on the left. Reasons for
this are unknown but it is not certain if the lying
position of the patients would not be a contributory
factor.
Curative treatment of any disease or its complication
can best be achieved by removing the cause(s) if
known. Among the pathogenetic mechanisms of the
neurological defects of CML suggested in literature
so far, hyperleucocytosis-induced stasis
(hyperviscosity syndrome) appears to be the most
predominant .This is said to slow down the
circulation through small blood vessels in the
brainstem and results in deafness . Leucostasis is
also known to predispose to a thrombus or plug
formation with subsequent occlusion of the internal
auditory artery, an end artery, thus producing
infarction in the inner ear . This pathogenetic
mechanism will respond to the conventional
cytoreductive measures . Cochlea lesion is said to
be due to haemorrhage in the inner ear, leukaemic
infiltration of the endolymphatic space or
haemorrhage in the perilymphatic space . Auditory
nerve lesion may be due to leukaemic infiltration in
the internal auditory meatus or in the auditory nerve
. The haemorrhagic mechanism will not respond to
cytoreductive measures alone while leukaemic
infiltration may do. Haemorrhage into ocular fundus
impairs vision while optic nerve infiltration causes
permanent blindness . In our case 4 patient, (Table
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